MXPA06000464A - Uso de biotina o un derivado de biotina para aclarar la piel y tratar manchas por envejecimiento. - Google Patents

Uso de biotina o un derivado de biotina para aclarar la piel y tratar manchas por envejecimiento.

Info

Publication number
MXPA06000464A
MXPA06000464A MXPA06000464A MXPA06000464A MXPA06000464A MX PA06000464 A MXPA06000464 A MX PA06000464A MX PA06000464 A MXPA06000464 A MX PA06000464A MX PA06000464 A MXPA06000464 A MX PA06000464A MX PA06000464 A MXPA06000464 A MX PA06000464A
Authority
MX
Mexico
Prior art keywords
biotin
age spots
treating age
derivative
lightening skin
Prior art date
Application number
MXPA06000464A
Other languages
English (en)
Inventor
Roland Jermann
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of MXPA06000464A publication Critical patent/MXPA06000464A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se relaciona al uso de biotina sola, preferentemente, sin embargo, con la vitamina C o un derivado de la misma, para la preparacion de una composicion cosmetica o de una composicion farmaceutica para propositos de aclaracion de la piel, para la eliminacion de irregularidades de color de la piel y para el tratamiento de lentigo senil.
MXPA06000464A 2003-08-26 2004-08-12 Uso de biotina o un derivado de biotina para aclarar la piel y tratar manchas por envejecimiento. MXPA06000464A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03018730 2003-08-26
PCT/EP2004/009048 WO2005020877A2 (de) 2003-08-26 2004-08-12 Verwendung von biotin oder einem biotinderivat zur aufhellung der haut und behandlung von altersflecken

Publications (1)

Publication Number Publication Date
MXPA06000464A true MXPA06000464A (es) 2006-04-11

Family

ID=34203219

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000464A MXPA06000464A (es) 2003-08-26 2004-08-12 Uso de biotina o un derivado de biotina para aclarar la piel y tratar manchas por envejecimiento.

Country Status (12)

Country Link
US (2) US20050048012A1 (es)
EP (2) EP1872772B1 (es)
JP (1) JP4755985B2 (es)
KR (1) KR101088604B1 (es)
CN (1) CN1842318B (es)
AT (1) ATE396695T1 (es)
BR (1) BRPI0414010B1 (es)
DE (1) DE502004007294D1 (es)
ES (2) ES2304161T3 (es)
MX (1) MXPA06000464A (es)
PL (1) PL1658039T3 (es)
WO (1) WO2005020877A2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007063224A (ja) * 2005-09-01 2007-03-15 Kobayashi Pharmaceut Co Ltd チロシナーゼ活性阻害剤
JP2007063223A (ja) * 2005-09-01 2007-03-15 Kobayashi Pharmaceut Co Ltd しみ又はそばかす予防又は治療用経口組成物及び食品
WO2007051596A1 (en) * 2005-11-03 2007-05-10 Dsm Ip Assets B.V. Novel retinyl biotinates and use thereof
DE102006047156A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninethylester und einem oder mehreren hautaufhellenden Wirkstoffen gegen unerwünschte Pigmentierung der Haut, insbesondere postinflammatorische Hyperpigmentierung
DE102006047157A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren hautaufhellenden Wirkstoffen gegen unerwünschte Pigmentierung der Haut, insbesondere postinflammatorische Hyperpigmentierung
FR2913198B1 (fr) * 2007-03-01 2009-06-05 Oreal Utilisation cosmetique d'une association de biotine et de vitamine cg.
EP2117652B1 (en) * 2007-03-12 2013-09-25 DSM IP Assets B.V. Cosmetic compositions
US20100087498A1 (en) * 2007-05-10 2010-04-08 Regina Goralczyk Use of biotin to prevent photoaging
DE102008008554A1 (de) * 2008-02-12 2009-08-13 Sebapharma Gmbh & Co. Kosmetische oder medizinische Zubereitung enthaltend Biotin
JP2009256326A (ja) * 2008-03-21 2009-11-05 Kose Corp 美白剤、及び皮膚外用剤
WO2015195404A1 (en) 2014-06-20 2015-12-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for detection of an analyte by movement of tethered microparticles
WO2016205239A1 (en) 2015-06-15 2016-12-22 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Non-hormonal mammalian sperm decoy contraception based on the n-terminus of the zp2 protein
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
CA3035584A1 (en) * 2016-09-01 2018-03-08 Jds Therapeutics, Llc Magnesium biotinate compositions and methods of use
EP3529205B1 (en) 2016-10-21 2022-06-15 The United States of America, as represented by the Secretary, Department of Health and Human Services Molecular nanotags
US10878941B2 (en) * 2017-05-22 2020-12-29 Zeyix Llc Perpetual bioinformatics and virtual colorimeter expert system
WO2019133727A1 (en) 2017-12-29 2019-07-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Universal influenza virus probe set for enrichment of any influenza virus nucleic acid
GB201800909D0 (en) * 2018-01-19 2018-03-07 Biocel Ltd Compositions and methods relating to amnion
US11701322B2 (en) 2018-03-23 2023-07-18 Mary Kay Inc. Topical compositions and methods
US11246886B2 (en) * 2018-09-06 2022-02-15 Nutrition 21, Llc Treatment of autism and autism spectrum disorders with biotin compositions
CA3165102A1 (en) 2019-12-16 2021-06-24 Nutrition 21, Llc Methods of production of arginine-silicate complexes
WO2022056078A1 (en) 2020-09-11 2022-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Rnase h-assisted detection assay for rna (radar)
CN114504549B (zh) * 2022-02-24 2023-11-24 北京斯利安药业有限公司 生物素的水性凝胶剂及其制备方法和应用
WO2024191684A1 (en) 2023-03-10 2024-09-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Detection of hepatitis c virus ribonucleic acid from whole blood using reverse transcription loop-mediated isothermal amplification

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH656067A5 (de) * 1981-12-10 1986-06-13 Richardson Vicks Inc Kosmetisches haarpflege- oder hautpflegemittel.
JPS6442414A (en) * 1987-08-10 1989-02-14 Kanebo Ltd Skin-beautifying cosmetic
JPH02215707A (ja) * 1989-02-15 1990-08-28 Chisso Corp 皮膚化粧料
GB9006785D0 (en) * 1990-03-27 1990-05-23 Leung Lit Hung Composition and methods for treatment of acne vulgaris and retardation of ageing
IT1254045B (it) * 1991-12-31 1995-09-06 Lifegroup Spa Derivati idrosolubili della biotina e relative composizioni terapeutiche
DE4242876C2 (de) * 1992-12-18 1997-11-27 Beiersdorf Ag Kosmetische und/oder dermatologische Zubereitungen zur kosmetischen und/oder dermatologischen Pflege der Haut und/oder der Hautanhangsgebilde
JPH0797322A (ja) * 1993-09-29 1995-04-11 Shiseido Co Ltd 一重項酸素消去剤
JPH07233046A (ja) * 1993-12-28 1995-09-05 Kose Corp 外用剤
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
WO1997025883A1 (de) * 1996-01-17 1997-07-24 Friedrich Kisters Aminosäuren-präparat zur haarwuchsförderung
DE19701651A1 (de) * 1997-01-18 1998-07-23 Rovi Gmbh Handelsgesellschaft Wäßrige Zusammensetzung mit biotinhaltigen Liposomen
IN2000KO00299A (es) * 1999-05-28 2005-11-18 Johnson & Johnson Consumer
US6551604B1 (en) * 1999-06-28 2003-04-22 The Procter & Gamble Company Skin care compositions
DE19941769A1 (de) * 1999-09-02 2001-03-08 Beiersdorf Ag Wirkstoffkombinationen bzw. Addukte aus Biotin und/oder Biotinderivaten und Cyclodextrinen und Verwendung solcher Wirkstoffkombinationen in kosmetischen Zubereitungen
JP4786127B2 (ja) * 2002-07-12 2011-10-05 任康 高田 色素沈着改善治療薬
MXPA05008216A (es) * 2003-01-31 2005-10-05 Procter & Gamble Medios para mejorar la apariencia del tejido queratinoso mamifero.
EP1449514A1 (de) * 2003-02-13 2004-08-25 Beiersdorf AG Hautpflegeprodukte mit Retinoiden, Ubichinonen sowie Biotin oder Carnitin

Also Published As

Publication number Publication date
EP1658039B1 (de) 2008-05-28
BRPI0414010B1 (pt) 2021-03-16
EP1872772B1 (de) 2015-08-05
ATE396695T1 (de) 2008-06-15
EP1658039A2 (de) 2006-05-24
ES2304161T3 (es) 2008-09-16
BRPI0414010A (pt) 2006-10-24
JP4755985B2 (ja) 2011-08-24
CN1842318A (zh) 2006-10-04
KR101088604B1 (ko) 2011-11-30
US20050048012A1 (en) 2005-03-03
CN1842318B (zh) 2011-04-13
PL1658039T3 (pl) 2008-10-31
US20070020206A1 (en) 2007-01-25
WO2005020877A3 (de) 2005-07-14
DE502004007294D1 (de) 2008-07-10
WO2005020877A2 (de) 2005-03-10
EP1872772A1 (de) 2008-01-02
KR20060069472A (ko) 2006-06-21
ES2547852T3 (es) 2015-10-09
JP2007503407A (ja) 2007-02-22

Similar Documents

Publication Publication Date Title
MXPA06000464A (es) Uso de biotina o un derivado de biotina para aclarar la piel y tratar manchas por envejecimiento.
MXPA03002080A (es) Derivados de resorcinol.
TW200616665A (en) Shatter resistant encapsulated colorants for natural skin appearance
TW200637522A (en) Skin treatment articles and methods
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
MY117805A (en) Resorcinol derivatives
WO2004021968A3 (en) Solution for ungual application
IL173123A0 (en) System and method for the photodynamic treatment of burns, wounds, and related skin disorders
WO2005089502A3 (en) Methods for the treatment of synucleinopathies
WO2001085106A3 (de) Kosmetisches mittel enthaltend 2-furanonderivate
WO2003080582A3 (de) Fredericamycin-derivate
AU2002366280A1 (en) Skin/hair equivalent with reconstructed papillae
WO2003104443A3 (de) Mesenchymale stammzellen des haarfollikels und deren verwendung
WO2002024613A3 (en) Resorcinol derivatives
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
EP1636160A4 (en) NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLISM AND SKIN DISEASES
MXPA05004535A (es) Unidad para dosificacion diaria de melatonina.
EP1582195A4 (en) BLEACHING, SKIN PREPARATION FOR OUTSIDE APPLICATION AND COSMETICS
IL166016A0 (en) Topical treatment of skin diseases
WO2002034233A3 (fr) Utilisation de l'association d'un carotenoide et d'un isoflavonoide pour traiter les signes cutanes du vieillissement
AP2001002274A0 (en) Rescorcinol derivatives.
WO2002034232A3 (fr) Utilisation de carotenoides pour traiter les signes cutanes du vieillissement
MX2007005615A (es) Agentes para el tratamiento del cabello o la piel que comprenden 3-piridinoles y/o 5-pirimidinoles.
AU2003238959A1 (en) Skin care products
WO2000061231A3 (en) Medical use